Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsBone & Joint HealthSubcutaneousOral (Elmiron formulation)

Pentosan Polysulfate

Also known as: PPS, Elmiron (oral formulation), Cartrophen (veterinary formulation)

A semi-synthetic polysulfated xylan with anti-inflammatory, anti-thrombotic, and chondroprotective properties. FDA-approved for interstitial cystitis (oral form, Elmiron) and widely used for osteoarthritis in veterinary medicine. Research suggests potential benefits for joint cartilage preservation and synovial fluid enhancement.

Research Status

Clinical Trials

Extensive Clinical Data

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Reduces joint inflammation and pain
Supports cartilage matrix preservation
Enhances synovial fluid viscosity
May slow osteoarthritis progression
Anti-thrombotic properties
Improves joint mobility and flexibility

Side Effects

Local injection site reactions (erythema, swelling, bruising)
CommonMild

Mild redness, swelling, or bruising at the injection site is common and typically resolves within 24-48 hours. Rotate injection sites to minimize tissue trauma. Apply ice for 5-10 minutes post-injection if needed.

Gastrointestinal upset (nausea, dyspepsia, diarrhea)
UncommonMild

More common with oral formulation (Elmiron). With subcutaneous injection, GI effects are uncommon. Take with food if nausea occurs. Discontinue if severe.

Headache
UncommonMild

Mild headaches have been reported in clinical trials. Usually self-resolving. Ensure adequate hydration.

Hair loss (alopecia)
RareMild

Rare cases of reversible alopecia have been reported with oral Elmiron, particularly with prolonged use. Mechanism unclear. Discontinue if significant hair loss occurs and consult a healthcare provider.

Bleeding or bruising tendency
UncommonModerate

Pentosan polysulfate has mild anticoagulant properties. Increased bruising or bleeding (nosebleeds, gum bleeding) may occur, especially if combined with anticoagulants or antiplatelet agents. Inform healthcare providers of concurrent anticoagulant use. Seek medical attention if bleeding is excessive.

Allergic reaction (rash, urticaria, angioedema)
RareSerious

Rare but serious allergic reactions including rash, hives, or angioedema have been reported. Discontinue immediately and seek emergency medical attention if signs of anaphylaxis (difficulty breathing, throat swelling, severe rash) occur.

Thrombocytopenia (low platelet count)
RareSerious

Very rare cases of thrombocytopenia have been reported with pentosan polysulfate. Monitor for signs of low platelets (unusual bruising, petechiae, bleeding gums). Baseline and periodic platelet counts are recommended with long-term use.

Liver function abnormalities
RareModerate

Rare elevations in liver enzymes have been reported. Baseline liver function tests and periodic monitoring are recommended, particularly with long-term use or in patients with pre-existing liver disease.

Retinal pigmentation changes (with oral formulation)
RareModerate

Rare cases of retinal pigmentation changes and visual disturbances have been reported with long-term oral Elmiron use (>5 years). Baseline and periodic ophthalmologic examination is recommended for long-term users. Less relevant for short-term subcutaneous research use.

Dosing Reference

ParameterValue
Dose range100-300 mg
Frequency2-3x weekly
TimingAny time of day
RouteSubcutaneous, Oral (Elmiron formulation)

Subcutaneous injection for joint health. Dosing based on veterinary and research protocols. Oral form (Elmiron) 100 mg three times daily for interstitial cystitis. For research purposes only.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Molecular weight4000-6000 Da (polysaccharide polymer, variable)
Half-lifeApproximately 1.3 hours (IV); tissue accumulation occurs with repeated dosing

Pentosan polysulfate is a semi-synthetic polysulfated xylan that exerts chondroprotective effects through multiple mechanisms: inhibition of inflammatory mediators and proteolytic enzymes that degrade cartilage matrix, enhancement of synovial fluid viscosity and lubrication, and modulation of the complement cascade. It also possesses anti-thrombotic properties and may stimulate endogenous hyaluronic acid production in synovial fluid.

Cartilage Matrix Protection

Inhibits matrix metalloproteinases (MMPs) and other proteolytic enzymes that break down cartilage collagen and proteoglycans, thereby slowing cartilage degradation in osteoarthritis.

Anti-inflammatory Signaling

Reduces production of pro-inflammatory cytokines (IL-1, TNF-α) and inhibits complement cascade activation, decreasing synovial inflammation and joint pain.

Synovial Fluid Enhancement

Increases synovial fluid viscosity and elasticity, improving joint lubrication and shock absorption, and may stimulate endogenous hyaluronic acid synthesis.

Anticoagulant Activity

Exhibits heparin-like anticoagulant properties through interaction with antithrombin III, reducing thrombotic risk.

  • Pentosan polysulfate is a polysaccharide, not a peptide in the classical sense, but is included in peptide research databases due to its biological activity and research applications.
  • Accumulates in cartilage and synovial tissue with repeated dosing, allowing for less frequent injection schedules.
  • FDA-approved oral formulation (Elmiron) for interstitial cystitis; injectable form widely used in veterinary orthopedics and human research.
  • Efficacy in human osteoarthritis remains mixed in clinical trials, though veterinary use shows consistent benefit.

Track your Pentosan Polysulfate research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Pentosan Polysulfate is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.